Sino Biological,Inc. commences an Equity Buyback Plan for CNY 200 million worth of its shares, under the authorization approved on February 19, 2024.

Sino Biological,Inc. (SZSE:301047) commences share repurchases on February 22, 2024, under the program mandated by shareholders in the Extraordinary General Meeting on February 19, 2024. As per the mandate, the company is authorized to repurchase up to CNY 200 million worth of its shares. The shares will be repurchased at no more than CNY 100 per share.

The purpose of the program is to reduce the share capital of the company. The repurchased shares will be cancelled. The company will use its own funds to repurchase the shares.

The authorization will be valid for 12 months.